Alkylating Drug [EPC]

142390 reported adverse events

Drugs of this class: BUSULFAN TEMOZOLOMIDE MITOMYCIN THIOTEPA IFOSFAMIDE CYCLOPHOSPHAMIDE DACARBAZINE CARMUSTINE CHLORAMBUCIL LOMUSTINE MECHLORETHAMINE HYDROCHLORIDE

These side effects are most commonly reported by patients taking drugs of the Alkylating Drug [EPC] class:

# Side effect Count
0 FEBRILE NEUTROPENIA 10301
1 NEUTROPENIA 8577
2 OFF LABEL USE 8299
3 PYREXIA 8037
4 THROMBOCYTOPENIA 5920
5 NAUSEA 5646
6 PRODUCT USE IN UNAPPROVED INDICATION 5324
7 DIARRHOEA 5256
8 PNEUMONIA 5142
9 SEPSIS 4940
See all common reactions for Alkylating Drug [EPC]

Drugs of the Alkylating Drug [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ENGRAFTMENT SYNDROME 214 0.6708
1 CYSTITIS VIRAL 106 0.6424
2 ENGRAFT FAILURE 114 0.5846
3 B-CELL TYPE ACUTE LEUKAEMIA 97 0.5843
4 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 147 0.5787
5 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 905 0.5746
6 ACUTE GRAFT VERSUS HOST DISEASE 1790 0.5672
7 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 440 0.5648
8 VENOOCCLUSIVE DISEASE 905 0.5621
9 IDIOPATHIC PNEUMONIA SYNDROME 93 0.5503
See all enriched reactions for Alkylating Drug [EPC]